KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Intangibles (2018 - 2026)

Takeda Pharmaceutical has reported Intangibles over the past 9 years, most recently at $21.8 billion for Q1 2026.

  • For Q1 2026, Intangibles fell 8.4% year-over-year to $21.8 billion; the TTM value through Mar 2026 reached $21.8 billion, down 8.4%, while the annual FY2026 figure was $22.7 billion, 4.72% down from the prior year.
  • Intangibles was $21.8 billion for Q1 2026 at Takeda Pharmaceutical, down from $23.8 billion in the prior quarter.
  • Across five years, Intangibles topped out at $32.9 billion in Q1 2022 and bottomed at $21.8 billion in Q1 2026.
  • The 5-year median for Intangibles is $28.8 billion (2024), against an average of $27.9 billion.
  • Year-over-year, Intangibles decreased 1.76% in 2023 and then dropped 17.48% in 2025.
  • Over 5 years, Intangibles stood at $32.9 billion in 2022, then decreased by 1.76% to $32.3 billion in 2023, then decreased by 10.64% to $28.8 billion in 2024, then dropped by 17.48% to $23.8 billion in 2025, then fell by 8.4% to $21.8 billion in 2026.
  • The last three reported values for Intangibles were $21.8 billion (Q1 2026), $23.8 billion (Q1 2025), and $28.8 billion (Q1 2024) per Business Quant data.